NCT05613478
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
Clinical trial condition
Immunotherapy
Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.
219 public trials
107 recruiting studies
Immunotherapy trial results
NCT06741982
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
NCT06603402
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
Recruiting
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
NCT06302062
- Conditions
- Advanced Solid Tumor, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +2 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Gaungdong, China
Recruiting
Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
NCT06702826
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
- Locations
-
- Xiangya Hospital, Central South University Changsha, Hunan, China
NCT06061276
- Conditions
- Adenocarcinoma, Camrelizumab, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
NCT06608160
- Conditions
- Immunotherapy, Lung Carcinoma, Lung Diseases, +7 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06510660
- Conditions
- Biomarkers, Carcinoma, Carcinoma, Squamous Cell, +14 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
NCT06571396
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Qilu hospital of Shandong university Jinan, Shandong, China
Recruiting
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
NCT06070636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China